Smith & Nephew (LON:SN) Share Price Crosses Above 200 Day Moving Average – Here’s Why

Shares of Smith & Nephew plc (LON:SN) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,204.02 and traded as high as GBX 1,389.50. Smith & Nephew shares last traded at GBX 1,368, with a volume of 1,898,609 shares traded.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Royal Bank Of Canada boosted their price target on shares of Smith & Nephew from GBX 1,400 to GBX 1,700 and gave the stock an “outperform” rating in a research report on Monday, October 20th. Berenberg Bank raised their target price on Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the company a “hold” rating in a research note on Thursday, August 7th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the stock a “hold” rating in a research report on Wednesday, August 6th. Finally, JPMorgan Chase & Co. upped their price target on shares of Smith & Nephew from GBX 1,357 to GBX 1,438 and gave the company an “overweight” rating in a report on Wednesday, August 6th. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of GBX 1,459.50.

Smith & Nephew Price Performance

The company’s 50 day moving average price is GBX 1,366.74 and its 200-day moving average price is GBX 1,204.02. The company has a market cap of £14.99 billion, a price-to-earnings ratio of 49.22, a PEG ratio of 0.46 and a beta of 0.62. The company has a debt-to-equity ratio of 70.22, a quick ratio of 0.84 and a current ratio of 2.51.

Insider Buying and Selling

In other Smith & Nephew news, insider Katarzyna Mazur Hofsaess acquired 541 shares of the stock in a transaction dated Friday, August 22nd. The shares were bought at an average price of GBX 1,385 per share, with a total value of £7,492.85. Also, insider David King acquired 2,800 shares of the stock in a transaction dated Monday, August 18th. The stock was acquired at an average cost of GBX 3,631 per share, for a total transaction of £101,668. Over the last three months, insiders have acquired 4,811 shares of company stock worth $12,947,701. 0.19% of the stock is owned by insiders.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.